Technical Analysis for ATHJF - Antisense Therap Ltd

Grade Last Price % Change Price Change
grade B 0.051 -5.20% -0.0028
ATHJF closed down 5.2 percent on Friday, January 17, 2020, on 39 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Down
Historical ATHJF trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 20 DMA Bearish -5.20%
Older signals for ATHJF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Antisense Therapeutics Limited, a biopharmaceutical drug discovery and development company, engages in the research and development of antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor targeting VLA-4 that has completed Phase IIa for the treatment of multiple sclerosis and asthma; and ATL1101, an antisense inhibitor of CD49d for the treatment of inflammation associated with duchenne muscular dystrophy. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Therapeutics Limited is based in Toorak, Australia.
Biotechnology Branches Of Biology Pharmaceuticals Life Sciences Biology Diseases Medication Drug Discovery Inflammation Asthma Gene Therapy Multiple Sclerosis Duchenne Muscular Dystrophy Treatment Of Multiple Sclerosis Sense

Is ATHJF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.075
52 Week Low 0.014
Average Volume 20,498
200-Day Moving Average 0.0000
50-Day Moving Average 0.0426
20-Day Moving Average 0.0592
10-Day Moving Average 0.0585
Average True Range 0.0067
ADX 10.06
+DI 47.0588
-DI 48.6631
Chandelier Exit (Long, 3 ATRs ) 0.0549
Chandelier Exit (Short, 3 ATRs ) 0.0622
Upper Bollinger Band 0.0743
Lower Bollinger Band 0.0441
Percent B (%b) 0.23
BandWidth 51.0135
MACD Line 0.0038
MACD Signal Line 0.0057
MACD Histogram -0.0019
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0510
Resistance 3 (R3) 0.0510 0.0510 0.0510
Resistance 2 (R2) 0.0510 0.0510 0.0510 0.0510
Resistance 1 (R1) 0.0510 0.0510 0.0510 0.0510 0.0510
Pivot Point 0.0510 0.0510 0.0510 0.0510 0.0510
Support 1 (S1) 0.0510 0.0510 0.0510 0.0510 0.0510
Support 2 (S2) 0.0510 0.0510 0.0510 0.0510
Support 3 (S3) 0.0510 0.0510 0.0510
Support 4 (S4) 0.0510